1. Home
  2. EVAX vs OP Comparison

EVAX vs OP Comparison

Compare EVAX & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • OP
  • Stock Information
  • Founded
  • EVAX 2008
  • OP 2021
  • Country
  • EVAX Denmark
  • OP Greece
  • Employees
  • EVAX N/A
  • OP N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • OP
  • Sector
  • EVAX Health Care
  • OP
  • Exchange
  • EVAX Nasdaq
  • OP Nasdaq
  • Market Cap
  • EVAX 17.8M
  • OP 14.3M
  • IPO Year
  • EVAX 2021
  • OP N/A
  • Fundamental
  • Price
  • EVAX $2.99
  • OP $1.29
  • Analyst Decision
  • EVAX Strong Buy
  • OP
  • Analyst Count
  • EVAX 2
  • OP 0
  • Target Price
  • EVAX $10.00
  • OP N/A
  • AVG Volume (30 Days)
  • EVAX 71.6K
  • OP 1.1M
  • Earning Date
  • EVAX 10-30-2025
  • OP 08-08-2025
  • Dividend Yield
  • EVAX N/A
  • OP N/A
  • EPS Growth
  • EVAX N/A
  • OP N/A
  • EPS
  • EVAX N/A
  • OP N/A
  • Revenue
  • EVAX $3,176,000.00
  • OP $19,435,000.00
  • Revenue This Year
  • EVAX N/A
  • OP N/A
  • Revenue Next Year
  • EVAX $425.50
  • OP N/A
  • P/E Ratio
  • EVAX N/A
  • OP N/A
  • Revenue Growth
  • EVAX 1042.45
  • OP N/A
  • 52 Week Low
  • EVAX $1.20
  • OP $1.07
  • 52 Week High
  • EVAX $17.20
  • OP $79.25
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 54.61
  • OP 32.87
  • Support Level
  • EVAX $2.81
  • OP $1.19
  • Resistance Level
  • EVAX $3.04
  • OP $1.21
  • Average True Range (ATR)
  • EVAX 0.21
  • OP 0.09
  • MACD
  • EVAX 0.00
  • OP 0.67
  • Stochastic Oscillator
  • EVAX 80.61
  • OP 43.91

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.

Share on Social Networks: